# A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.

Study · id `cardio:ct-nct02156349` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02156349](<https://clinicaltrials.gov/study/NCT02156349>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02156349

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 558 participants.

## Technical summary

Registry record NCT02156349. Randomized; no masking; primary purpose diagnostic. Start 2014-05-14 (actual); primary completion 2017-04-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 558 participants (enrolled count; ClinicalTrials.gov record NCT02156349, source copy `cardio:ctgov-nct02156349-2017-11-14`, retrieved 2026-10-26)
- Started: 2014-05-14 (actual) (ClinicalTrials.gov record NCT02156349, source copy `cardio:ctgov-nct02156349-2017-11-14`, retrieved 2026-10-26)
- Primary completion: 2017-04-10 (actual) (ClinicalTrials.gov record NCT02156349, source copy `cardio:ctgov-nct02156349-2017-11-14`, retrieved 2026-10-26)
- Completion: 2017-04-10 (actual) (ClinicalTrials.gov record NCT02156349, source copy `cardio:ctgov-nct02156349-2017-11-14`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT02156349, source copy `cardio:ctgov-nct02156349-2017-11-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02156349-2017-11-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.
- Acronym: PDMProValueDSP
- Condition: Type II Diabetes Mellitus
- Intervention (Device): Accu-Chek Smart Pix Software
- Intervention (Device): Accu-Chek Smart Pix readout Device
- Lead sponsor: Hoffmann-La Roche
- Lead sponsor class: INDUSTRY
- Collaborator: Roche Diabetes Care
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Hoffmann-La Roche (`cardio:org-hoffmann-la-roche`)
- Registry lists this organization as a collaborator: Roche Diabetes Care (`cardio:org-roche-diabetes-care`)

## Provenance

Content hash: 497e5631efce3d5418c7346bc32bc30e95270a6d757d2501c95355e3d482cc05
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
